US Stock MarketDetailed Quotes

ELYM Eliem Therapeutics

Watchlist
  • 8.810
  • +0.120+1.38%
Close Jun 14 16:00 ET
  • 8.910
  • +0.100+1.14%
Post 16:02 ET
262.12MMarket Cap-16942P/E (TTM)

Eliem Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-87.18%3.01M
-10.77%40.28M
-46.39%5.12M
-42.83%5M
-51.00%6.71M
78.48%23.44M
26.53%45.14M
-10.74%9.55M
-6.77%8.75M
57.36%13.7M
Selling and administrative expenses
-89.20%1.91M
31.41%24.86M
-56.88%2M
-52.67%2.13M
-38.65%3.03M
263.67%17.72M
53.21%18.92M
21.00%4.63M
32.29%4.49M
69.25%4.93M
-General and administrative expense
-89.20%1.91M
31.41%24.86M
-56.88%2M
-52.67%2.13M
-38.65%3.03M
263.67%17.72M
53.21%18.92M
21.00%4.63M
32.29%4.49M
69.25%4.93M
Research and development costs
-80.93%1.09M
-41.21%15.41M
-36.53%3.13M
-32.46%2.88M
-57.94%3.69M
-30.75%5.72M
12.40%26.21M
-28.38%4.93M
-28.90%4.26M
51.37%8.77M
Operating profit
87.18%-3.01M
10.77%-40.28M
46.39%-5.12M
42.83%-5M
51.00%-6.71M
-78.48%-23.44M
-26.53%-45.14M
10.74%-9.55M
6.77%-8.75M
-57.36%-13.7M
Net non-operating interest income expense
49.00%1.34M
236.00%4.62M
77.50%1.35M
229.24%1.26M
900K
1.38M
760K
383K
Non-operating interest income
49.00%1.34M
236.00%4.62M
77.50%1.35M
229.24%1.26M
----
--900K
--1.38M
--760K
--383K
----
Other net income (expense)
-113.31%-33K
136.12%536K
-87.21%132K
82.69%-228K
266.93%1.49M
444.44%248K
87.43%-1.48M
553.16%1.03M
-467.67%-1.32M
-7,358.33%-895K
Gain on sale of security
-113.31%-33K
136.12%536K
-87.21%132K
82.69%-228K
136.85%384K
257.96%248K
-772.94%-1.48M
953.06%1.03M
-422.62%-1.32M
-8,583.33%-1.04M
Other non- operating income (expenses)
----
----
----
----
655.10%1.11M
----
----
----
----
--147K
Income before tax
92.39%-1.7M
22.38%-35.12M
53.09%-3.64M
59.02%-3.97M
64.24%-5.22M
-68.81%-22.29M
4.71%-45.24M
26.39%-7.76M
-0.70%-9.68M
-67.40%-14.6M
Income tax
Net income
92.39%-1.7M
22.38%-35.12M
53.09%-3.64M
59.02%-3.97M
64.24%-5.22M
-68.81%-22.29M
4.71%-45.24M
26.39%-7.76M
-0.70%-9.68M
-67.40%-14.6M
Net income continuous Operations
92.39%-1.7M
22.38%-35.12M
53.09%-3.64M
59.02%-3.97M
64.24%-5.22M
-68.81%-22.29M
4.71%-45.24M
26.39%-7.76M
-0.70%-9.68M
-67.40%-14.6M
Minority interest income
Net income attributable to the parent company
92.39%-1.7M
22.38%-35.12M
53.09%-3.64M
59.02%-3.97M
64.24%-5.22M
-68.81%-22.29M
4.71%-45.24M
26.39%-7.76M
-0.70%-9.68M
-67.40%-14.6M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
92.39%-1.7M
22.38%-35.12M
53.09%-3.64M
59.02%-3.97M
64.24%-5.22M
-68.81%-22.29M
13.04%-45.24M
26.39%-7.76M
11.47%-9.68M
-34.40%-14.6M
Basic earnings per share
92.86%-0.06
24.42%-1.3
55.17%-0.13
59.46%-0.15
66.07%-0.19
-68.00%-0.84
59.43%-1.72
27.50%-0.29
47.14%-0.37
-20.96%-0.56
Diluted earnings per share
92.86%-0.06
24.42%-1.3
55.17%-0.13
59.46%-0.15
66.07%-0.19
-68.00%-0.84
59.43%-1.72
27.50%-0.29
47.14%-0.37
-20.96%-0.56
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -87.18%3.01M-10.77%40.28M-46.39%5.12M-42.83%5M-51.00%6.71M78.48%23.44M26.53%45.14M-10.74%9.55M-6.77%8.75M57.36%13.7M
Selling and administrative expenses -89.20%1.91M31.41%24.86M-56.88%2M-52.67%2.13M-38.65%3.03M263.67%17.72M53.21%18.92M21.00%4.63M32.29%4.49M69.25%4.93M
-General and administrative expense -89.20%1.91M31.41%24.86M-56.88%2M-52.67%2.13M-38.65%3.03M263.67%17.72M53.21%18.92M21.00%4.63M32.29%4.49M69.25%4.93M
Research and development costs -80.93%1.09M-41.21%15.41M-36.53%3.13M-32.46%2.88M-57.94%3.69M-30.75%5.72M12.40%26.21M-28.38%4.93M-28.90%4.26M51.37%8.77M
Operating profit 87.18%-3.01M10.77%-40.28M46.39%-5.12M42.83%-5M51.00%-6.71M-78.48%-23.44M-26.53%-45.14M10.74%-9.55M6.77%-8.75M-57.36%-13.7M
Net non-operating interest income expense 49.00%1.34M236.00%4.62M77.50%1.35M229.24%1.26M900K1.38M760K383K
Non-operating interest income 49.00%1.34M236.00%4.62M77.50%1.35M229.24%1.26M------900K--1.38M--760K--383K----
Other net income (expense) -113.31%-33K136.12%536K-87.21%132K82.69%-228K266.93%1.49M444.44%248K87.43%-1.48M553.16%1.03M-467.67%-1.32M-7,358.33%-895K
Gain on sale of security -113.31%-33K136.12%536K-87.21%132K82.69%-228K136.85%384K257.96%248K-772.94%-1.48M953.06%1.03M-422.62%-1.32M-8,583.33%-1.04M
Other non- operating income (expenses) ----------------655.10%1.11M------------------147K
Income before tax 92.39%-1.7M22.38%-35.12M53.09%-3.64M59.02%-3.97M64.24%-5.22M-68.81%-22.29M4.71%-45.24M26.39%-7.76M-0.70%-9.68M-67.40%-14.6M
Income tax
Net income 92.39%-1.7M22.38%-35.12M53.09%-3.64M59.02%-3.97M64.24%-5.22M-68.81%-22.29M4.71%-45.24M26.39%-7.76M-0.70%-9.68M-67.40%-14.6M
Net income continuous Operations 92.39%-1.7M22.38%-35.12M53.09%-3.64M59.02%-3.97M64.24%-5.22M-68.81%-22.29M4.71%-45.24M26.39%-7.76M-0.70%-9.68M-67.40%-14.6M
Minority interest income
Net income attributable to the parent company 92.39%-1.7M22.38%-35.12M53.09%-3.64M59.02%-3.97M64.24%-5.22M-68.81%-22.29M4.71%-45.24M26.39%-7.76M-0.70%-9.68M-67.40%-14.6M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 92.39%-1.7M22.38%-35.12M53.09%-3.64M59.02%-3.97M64.24%-5.22M-68.81%-22.29M13.04%-45.24M26.39%-7.76M11.47%-9.68M-34.40%-14.6M
Basic earnings per share 92.86%-0.0624.42%-1.355.17%-0.1359.46%-0.1566.07%-0.19-68.00%-0.8459.43%-1.7227.50%-0.2947.14%-0.37-20.96%-0.56
Diluted earnings per share 92.86%-0.0624.42%-1.355.17%-0.1359.46%-0.1566.07%-0.19-68.00%-0.8459.43%-1.7227.50%-0.2947.14%-0.37-20.96%-0.56
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg